RJ

Ranjana Jha

Active Director Director DIN 07947744
DIN 07947744 First appointment Sep 2017
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Sep 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Ranjana Jha

Data last updated:

Ranjana Jha is a Director at Calical Drugs (Opc) Private Limited (since 2023). Earlier, Ranjana Jha was a Director at Max Lifesciences Private Limited (from 2017).

DIN 07947744
Primary Designation Director
First Appointment 01 Sep 2017
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Calical Drugs (Opc) Private Limited U47721BR2023OPC062651
Director19 Apr 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Max Lifesciences Private Limited U51101BR2015PTC024518
Director01 Sep 20172015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Max Lifesciences Private Limited
Calical Drugs (Opc) Private Limited
Premium access

Shareholding and investment profile for Ranjana Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjana Jha

Ranjana Jha currently holds 1 directorship: Calical Drugs (Opc) Private Limited (Director, since 19 Apr 2023).

Ranjana Jha was first appointed on 01 Sep 2017 as Director at Max Lifesciences Private Limited. The most recent appointment on record is 19 Apr 2023 at Calical Drugs (Opc) Private Limited.

Ranjana Jha held 1 earlier board appointment: Max Lifesciences Private Limited (Director, from 01 Sep 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available